13F
中

CPIX CUMBERLAND PHARMACEUTICALS

2026Q1 · CUSIP 230770109 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
29
Δ holders QoQ
+2
Breadth percentile
n/a
Whale holders
14
Δ whales
+1
Inst. holding value
$9M
New positions
9
Closed positions
7
Price momentum (1Q)
—
Put / Call
3/3

Breadth history (34 quarters)

2018Q1: Δ-2 · h=29 2018Q2: Δ+1 · h=30 2018Q3: Δ+4 · h=34 2018Q4: Δ-6 · h=28 2019Q1: Δ-4 · h=24 2019Q2: Δ+1 · h=25 2019Q3: Δ+4 · h=29 2019Q4: Δ+1 · h=30 2020Q1: Δ-3 · h=27 2020Q2: Δ+4 · h=31 2020Q3: Δ-3 · h=28 2020Q4: Δ+1 · h=29 2021Q1: Δ+3 · h=32 2021Q2: Δ-3 · h=29 2021Q3: Δ-5 · h=24 2021Q4: Δ+3 · h=27 2022Q1: Δ+0 · h=27 2022Q2: Δ-4 · h=23 2022Q3: Δ-5 · h=18 2022Q4: Δ+6 · h=24 2023Q1: Δ-2 · h=22 2023Q2: Δ+2 · h=24 2023Q3: Δ-2 · h=22 2023Q4: Δ+4 · h=26 2024Q1: Δ-2 · h=24 2024Q2: Δ+0 · h=24 2024Q3: Δ-1 · h=23 2024Q4: Δ-2 · h=21 2025Q1: Δ+13 · h=34 2025Q2: Δ-2 · h=32 2025Q3: Δ-2 · h=30 2025Q4: Δ-3 · h=27 2026Q1: Δ+2 · h=29 2018Q1: holders=29 2018Q2: holders=30 2018Q3: holders=34 2018Q4: holders=28 2019Q1: holders=24 2019Q2: holders=25 2019Q3: holders=29 2019Q4: holders=30 2020Q1: holders=27 2020Q2: holders=31 2020Q3: holders=28 2020Q4: holders=29 2021Q1: holders=32 2021Q2: holders=29 2021Q3: holders=24 2021Q4: holders=27 2022Q1: holders=27 2022Q2: holders=23 2022Q3: holders=18 2022Q4: holders=24 2023Q1: holders=22 2023Q2: holders=24 2023Q3: holders=22 2023Q4: holders=26 2024Q1: holders=24 2024Q2: holders=24 2024Q3: holders=23 2024Q4: holders=21 2025Q1: holders=34 2025Q2: holders=32 2025Q3: holders=30 2025Q4: holders=27 2026Q1: holders=29 -13 -6.5 +0 +6.5 +13 162636 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q1 Top 19% — —

Options Sentiment

Put holders
3
QoQ: +1
Call holders
3
QoQ: +1

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-0.49
EPS YoY
—
Revenue (TTM)
$0.0B
Revenue YoY
+2.1%
Quarterly Revenue & EPS (4Y)
2022-06-30: $10M 2022-09-30: $11M 2022-12-31: $9M 2023-03-31: $9M 2023-06-30: $11M 2023-09-30: $10M 2023-12-31: $9M 2024-03-31: $8M 2024-06-30: $10M 2024-09-30: $9M 2024-12-31: $10M 2025-03-31: $12M 2025-06-30: $11M 2025-09-30: $8M 2025-12-31: $14M 2026-03-31: $9M 2022-06-30: EPS -0.09 2022-09-30: EPS -0.03 2022-12-31: EPS -0.17 2023-03-31: EPS 0.01 2023-06-30: EPS 0.06 2023-09-30: EPS -0.07 2023-12-31: EPS -0.44 2024-03-31: EPS -0.14 2024-06-30: EPS -0.08 2024-09-30: EPS -0.11 2024-12-31: EPS -0.14 2025-03-31: EPS 0.08 2025-06-30: EPS -0.05 2025-09-30: EPS -0.13 2025-12-31: EPS -0.09 2026-03-31: EPS -0.22 0M 7M 14M $M -0.48 -0.20 0.09 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)